Member Info for tomvisual

Carl's done a fantastic job.
Now we have the Holy Grail insight, an LFT.
WoW. Not one test method but TWO!!
These test assays will be fast, sensitive and specific.
Is this the "New Technology" mentioned in the Commons by Hanc ock on Monday 14th Dec?
Saturday was referenced!
OMG!!
Look at the market cap here!! £8M!!
Thus could be £500M worth if orders easy.
The recent £912M Tender fror announcement 17/12/20 was cancelled earlier in the week!
The planets are aligning, the Star of Bethlehem is aligning next week after 600 years and Carl's 2 tests will be amazing!!!

Carl's test - fast (tick), sensitive (tick), specific (tick)
Test, test, test

CS, when does the decision on the second tranche order need to made by?

Test, test, test

Syme, Syme and more Syme!
Just add

Hahaha, said it before but will say it again, tgats some crystal ball you have!
1.25p, ouch.

You mentioned cconcern of the Market cap here and that you are out.
Is £3.5M reasonable??
Would this get you back in??

Test, test, test

Nice opportunity for another top up.
Bring it on AZ!!

Someone mention on the NCYT BB that Innova stock will be available to end of Feb.

Then no doubt plan B kicks in!
Question is are we part of Plan B?

Test, test, test

TonytFawcett, you need to see other posts on this BB. Provided tests are done on a regular basis (3 days?) then Harvard analysis was happy for 50% Sensitivity.
Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance.
https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v3
and
https://m.youtube.com/watch?v=h7Sv_pS8MgQ

That's what sold the Innova LFT to the Government. Professor Deeks has now contested this.
https://mobile.twitter.com/deeksj/status/1326595804144996352?s=19
I would argue its better to run a screening process!
However, I may question the 3 day time period between tests. However, if someone has a positive I assume tgey are tested daily. Nick Gibbs implied this to be the case!
The direction of travel must be a better test with better sensitivity. The Avacta's LFT.
The $64M question when is it available??

MHRA Guidelines
Acceptable Sens > 80%, Spec > 95%
Desired Sens > 97%, Spec > 99%

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/895745/TPP_Point_of_Care_SARS-CoV-2_Detection_Tests.pdf

No antigen test meets MHRA desired criterion.
Will Avacta's??

Test, test, test

R4 Today 18/12/20 @ 7:49. Nick Gibbs
5.5M students tested twice three days apart to check break of the transmission of the virus after the Christmas break. Mass testing.
Guidance in middle of holidays!!
Due to logistics, this will be the Innova LFT.
Test process has already been trialled in some schools. That's why anterior swabs were required. Prrocess Conformity.

Test, test, test

Craiga, hiw recent is this information?
If very recent it could imply a direct clinical comparison between the collection methods.
Big data?

Test, test, test

Guys, the race commences next week

Test, test, test

Argo007, thanks. That's my conclusion.
If we get to Monday (with my main trio), I would conclude Syme will deliver rns first.

Waiting on Avacta and EUA and Syme?
Anyone else in the same quandary??
3 horses must be better than one??
Comments welcomed!!

FB, excellent post.
Could Syme link to AI?
Page 51 of the Pdf means we would potentially be firing on more cylinders!!

Excellent post AgentB!
What's keeping Biris from reaching the same conclusions??

Tesr, test, test

Monkshood, what about the Brucker AN?

https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/Separations_MassSpectrometry/Literature/ApplicationNotes/1881181_MT-128_SARS-CoV-2_Antigen_Assay_ebook.pdf

Test, test, test

Hahaha, it gets worse...
Avacta have probably just started clinical trials!

Test, test, test

Haha, as you stated he can now sell up his entire holding here.
The share option from today's RNS is his guarantee to his grave!!

No, to me they have planted a seed that has 10 years to grow and offers shareholders dilution if they take up the option!

WoW 2.3M share options @ 17p until 2030!!
Braveheart announces that, pursuant to the Share Option Plan, Trevor Brown and Vivian Hallam, both directors of Braveheart and persons discharging managerial responsibilities ("PDMR") of the Company have been granted options over 1,200,000 and 500,000 Ordinary Shares of 2 pence each in the Group ("Ordinary Shares"), respectively, at an exercise price of 17p per share, being the closing mid-market price on 16 December 2020. The options vest with immediate effect and are exercisable up to 16 December 2030.

A further 650,000 options over Ordinary Shares have been granted to employees and consultants of the Group, on the same terms as above.

Nice dilution potential down the line!!
Seems King Trev's legacy goes on for another decade here too!

Test, test, test

Researching...

Interesting recent increase in orders for Biodot
https://bidstats.uk/tenders/?q=Lft#741146623-739704994-60

LFD
https://www.biodot.com/lateral-flow/

Drill further and 500M antigen tests are mentioned for the US
https://www.biodot.com/us-plans-for-hundreds-of-millions-of-cheap-fast-covid-19-tests/

Which lead me to
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30421-1/fulltext

A LFT that looks better than Innova offering from Abbott.
Sir Al needs to get a move on, "every man and his dog" appears to be beating on the door with a LFT!
Just need one that meets MHRA Desired Guidelines. Do Avacta have the LFT Grail?

Test, test, test